Funding for this research was provided by:
Howard Hughes Medical Institute (55008729)
National Health and Medical Research Council (1085015, 1106444, 1128984)
Text and Data Mining valid from 2019-06-20
Received: 13 March 2019
Accepted: 21 May 2019
First Online: 20 June 2019
: B.E.K., O.B., H.P.M., R.G.K., A.D., N.K., and R.K.P. are employees of GlaxoSmithKline. M.A.D. has been a member of advisory boards for CTX CRC, Storm Therapeutics, Celgene and Cambridge Epigenetix. The remaining authors declare no competing interests.